Details of the Drug

General Information of Drug (ID: DMB7JS4)

• Drug Name: Anti-CD19 CAR-T cell therapy

Indication

Disease Entry	ICD 11	Status	REF
B-cell lymphoma	2A86	Phase 1	[1]
Haematological malignancy	2B33.Y	Phase 1	[1]
Lymphoma	2A80-2A86	Phase 1	[2]

• Cross-matching ID: TTD ID: D0WM7M
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)